Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-069396
Filing Date
2025-07-21
Accepted
2025-07-21 19:50:39
Documents
1
Period of Report
2025-07-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2521348-12_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2521348-12_4seq1.xml 4 29967
  Complete submission text file 0001104659-25-069396.txt   31410
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLUEPRINT MEDICINES CORP. 214 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Landsittel Michael (Reporting) CIK: 0001651036 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 251138378